COMBINATION OF ACYLATED GLUCAGON ANALOGUES WITH INSULIN ANALOGUES
First Claim
Patent Images
1. A combination of compounds for use in a method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, wherein said method comprises administering to a mammalian subject a combination of compounds comprising;
(a) a compound having the formula;
R1—
Z—
R2 wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl;
R2 is OH or NH2;
and Z is a peptide having the formula I;
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to methods for treating metabolic disorders, including diabetes by using a combination of an acylated glucagon analogue and an insulin analogue. The invention also features a kit that includes an acylated glucagon analogue and an insuline analogue.
19 Citations
111 Claims
-
1. A combination of compounds for use in a method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, wherein said method comprises administering to a mammalian subject a combination of compounds comprising;(a) a compound having the formula;
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula I; - View Dependent Claims (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 107, 108, 109, 110, 111)
- promoting weight loss;
-
2. Use of (a) a compound having the formula:
-
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula I; - View Dependent Claims (3, 4)
-
-
5. A method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, said method comprising administering to a mammalian subject a combination of compounds comprising;(a) a compound having the formula;
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula I;
- promoting weight loss;
-
44. A combination of compounds for use in a method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, said method comprising administering to a mammalian subject a combination of compounds comprising;(a) a compound having the formula;
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula V; - View Dependent Claims (49, 50, 51, 52, 53, 54, 55, 56, 57)
- promoting weight loss;
-
45. Use of (a) a compound having the formula:
-
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula V; - View Dependent Claims (46, 47)
-
-
48. A method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, said method comprising administering to a mammalian subject a combination of compounds comprising;(a) a compound having the formula;
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula V;
- promoting weight loss;
-
58. A combination of compounds for use in a method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, said method comprising administering to a mammalian subject a combination of compounds comprising;(a) a compound having the formula;
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula VI; - View Dependent Claims (63, 64, 65, 66, 67, 68, 69, 70)
- promoting weight loss;
-
59. Use of (a) a compound having the formula:
-
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula VI; - View Dependent Claims (60, 61)
-
-
62. A method for preventing or reducing weight gain;
- promoting weight loss;
improving circulating glucose levels, glucose tolerance or circulating cholesterol levels;
lowering circulating LDL levels;
increasing HDL/LDL ratio;
or treating a condition caused or characterized by excess body weight, said method comprising administering to a mammalian subject a combination of compounds comprising;(a) a compound having the formula;
R1—
Z—
R2wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl, or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula VI;
- promoting weight loss;
Specification